Clinical trial
A Study for Patients With Relapsing Remitting Multiple Sclerosis
NCT00869986
Study timeline
Study start (unknown)2006-11-01Date precision: month
Registry last updated2010-09-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
dirucotideDRUG
placeboDRUG
Sponsors & collaborators
Eli Lilly and Companylead sponsor
BioMS Technology Corp.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00869986 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.